Research On Financial Performance Of HY Company’s Asset-light Operation Model

With the rapid economic development and the gradual improvement of people’s living standards,the domestic pharmaceutical market has developed rapidly in recent years.It leapfrogged Japan in2013 and became the world’s second largest pharmaceutical consumer market.The rise of pharmaceutical companies has brought the domestic pharmaceutical market into a stage of fierce competition.In view of the frequent occurrence of accidents in the pharmaceutical industry and high drug prices,the government has issued a number of policies to strengthen the control of the pharmaceutical industry.The implementation of the "two-vote system" in 2017 aims to reduce the intermediate links of pharmaceutical circulation and reduce drug prices.The production environment is getting tougher.In this context,companies must adjust their business models to gain a place.Modern enterprises are not only the competition between products,but also the competition of business models.A suitable business model can maximize the use of limited resources of the enterprise and promote the development of the enterprise.Therefore,more and more enterprises are beginning to try the asset-light operation mode.This article takes HY company as a case study object to study and analyze the financial performance of HY company under the asset-light operation mode.First combed the relevant literature and theories;then analyzed the HY company’s asset-light operation approach,and analyzed the financial performance status of HY company under the 2013-2019 young asset operation model through financial index analysis and comparative analysis method,and found HY company finance Problems and reasons for performance;finally put forward relevant suggestions and measures in a targeted manner.Through research on the above aspects of HY company,it is concluded that HY company’s asset-light operating model has a good impact on financial performance,which enhances its research and development capabilities,endless emergence of new drug products,improves the company’s core competitiveness,and enhances the company’s equity value.Accelerate the pace of transformation to an innovative pharmaceutical company;at the same time,it also brings some problems to HY company,such as increased financial risks,excessive sales expenses,and reduction of operating profit.Therefore,HY company should use its light-weight operation in accordance with its own characteristics.mode.Finally,I hope that through the research in this article,we can provide some reference and inspiration for other pharmaceutical companies that implement theasset-light operation mode,and promote better development of the pharmaceutical industry.